Levopropoxifeno Uses, Dosage, Side Effects and more
Levopropoxifeno is a stereoisomer of propoxyphene in the form of 2S, 3R enantiomer. It was sold as an antitussive, but it was removed from the market in the 70s. Levopropoxifeno was developed by Lilly and FDA approved on March 21st, 1962. This drug presented different dosages and it was administered as a capsule or suspension.
| Trade Name | Levopropoxifeno |
| Generic | Levopropoxyphene |
| Levopropoxyphene Other Names | (l)-Propoxyphene, levopropoxifeno, Levopropoxyphene |
| Type | |
| Formula | C22H29NO2 |
| Weight | Average: 339.479 Monoisotopic: 339.219829178 |
| Groups | Withdrawn |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Levopropoxifeno was used as an antitussive. An antitussive is a medication often recommended for the treatment of cough and associated respiratory tract disorders. Its enantiomer, dextropropoxyphene, presents an analgesic effect.
